Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Phosphorylated α-synuclein in Parkinson's disease.

Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J.

Sci Transl Med. 2012 Feb 15;4(121):121ra20. doi: 10.1126/scitranslmed.3002566.

PMID:
22344688
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.

Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM.

Neurobiol Dis. 2012 Jan;45(1):188-95. doi: 10.1016/j.nbd.2011.08.003. Epub 2011 Aug 10.

PMID:
21856424
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.

Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG.

Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Erratum in: Lancet Neurol. 2011 Apr;10(4):297.

PMID:
21317042
[PubMed - indexed for MEDLINE]
4.

Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity.

van Dijk KD, Bidinosti M, Weiss A, Raijmakers P, Berendse HW, van de Berg WD.

Eur J Neurol. 2014 Mar;21(3):388-94. doi: 10.1111/ene.12176. Epub 2013 Apr 30.

PMID:
23631635
[PubMed - indexed for MEDLINE]
5.

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.

Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.

Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.

PMID:
19903734
[PubMed - indexed for MEDLINE]
Free Article
6.

CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.

Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A.

Parkinsonism Relat Disord. 2014 Apr;20(4):382-7. doi: 10.1016/j.parkreldis.2014.01.011. Epub 2014 Jan 22.

PMID:
24507721
[PubMed - indexed for MEDLINE]
7.

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.

Kang JH, Irwin DJ, Chen-Plotkin AS, Siderowf A, Caspell C, Coffey CS, Waligórska T, Taylor P, Pan S, Frasier M, Marek K, Kieburtz K, Jennings D, Simuni T, Tanner CM, Singleton A, Toga AW, Chowdhury S, Mollenhauer B, Trojanowski JQ, Shaw LM; Parkinson's Progression Markers Initiative.

JAMA Neurol. 2013 Oct;70(10):1277-87.

PMID:
23979011
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

Hall S, Öhrfelt A, Constantinescu R, Andreasson U, Surova Y, Bostrom F, Nilsson C, Håkan W, Decraemer H, Någga K, Minthon L, Londos E, Vanmechelen E, Holmberg B, Zetterberg H, Blennow K, Hansson O.

Arch Neurol. 2012 Nov;69(11):1445-52.

PMID:
22925882
[PubMed - indexed for MEDLINE]
9.

CSF α-synuclein does not differentiate between parkinsonian disorders.

Aerts MB, Esselink RA, Abdo WF, Bloem BR, Verbeek MM.

Neurobiol Aging. 2012 Feb;33(2):430.e1-3. doi: 10.1016/j.neurobiolaging.2010.12.001. Epub 2011 Jan 13.

PMID:
21236518
[PubMed - indexed for MEDLINE]
Free Article
10.

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.

Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J.

Brain. 2010 Mar;133(Pt 3):713-26. doi: 10.1093/brain/awq008. Epub 2010 Feb 15.

PMID:
20157014
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.

Sako W, Murakami N, Izumi Y, Kaji R.

Mov Disord. 2014 Nov;29(13):1599-605. doi: 10.1002/mds.26036. Epub 2014 Sep 25.

PMID:
25258345
[PubMed - in process]
12.

Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.

Holmberg B, Rosengren L, Karlsson JE, Johnels B.

Mov Disord. 1998 Jan;13(1):70-7.

PMID:
9452329
[PubMed - indexed for MEDLINE]
13.

Enteric GFAP expression and phosphorylation in Parkinson's disease.

Clairembault T, Kamphuis W, Leclair-Visonneau L, Rolli-Derkinderen M, Coron E, Neunlist M, Hol EM, Derkinderen P.

J Neurochem. 2014 Sep;130(6):805-15. doi: 10.1111/jnc.12742. Epub 2014 Jun 6.

PMID:
24749759
[PubMed - indexed for MEDLINE]
14.

Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression.

Song YJ, Halliday GM, Holton JL, Lashley T, O'Sullivan SS, McCann H, Lees AJ, Ozawa T, Williams DR, Lockhart PJ, Revesz TR.

J Neuropathol Exp Neurol. 2009 Oct;68(10):1073-83. doi: 10.1097/NEN.0b013e3181b66f1b.

PMID:
19918119
[PubMed - indexed for MEDLINE]
15.

[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].

Orimo S.

Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. Review. Japanese.

PMID:
18386627
[PubMed - indexed for MEDLINE]
16.

Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.

Holmberg B, Johnels B, Blennow K, Rosengren L.

Mov Disord. 2003 Feb;18(2):186-90.

PMID:
12539213
[PubMed - indexed for MEDLINE]
17.

Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.

Constantinescu R, Rosengren L, Johnels B, Zetterberg H, Holmberg B.

Parkinsonism Relat Disord. 2010 Feb;16(2):142-5. doi: 10.1016/j.parkreldis.2009.07.007. Epub 2009 Jul 31.

PMID:
19647470
[PubMed - indexed for MEDLINE]
18.

Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.

Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H.

Brain. 2008 Mar;131(Pt 3):642-50. Epub 2007 Dec 13.

PMID:
18079166
[PubMed - indexed for MEDLINE]
Free Article
19.

Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects.

Mollenhauer B, Trautmann E, Taylor P, Manninger P, Sixel-Döring F, Ebentheuer J, Trenkwalder C, Schlossmacher MG.

Neurosci Lett. 2013 Jan 4;532:44-8. doi: 10.1016/j.neulet.2012.11.004. Epub 2012 Nov 10.

PMID:
23149132
[PubMed - indexed for MEDLINE]
20.

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.

Parnetti L, Chiasserini D, Bellomo G, Giannandrea D, De Carlo C, Qureshi MM, Ardah MT, Varghese S, Bonanni L, Borroni B, Tambasco N, Eusebi P, Rossi A, Onofrj M, Padovani A, Calabresi P, El-Agnaf O.

Mov Disord. 2011 Jul;26(8):1428-35. doi: 10.1002/mds.23670. Epub 2011 Apr 5.

PMID:
21469206
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk